» Articles » PMID: 9197263

An Animal Model for Acute and Persistent Epstein-Barr Virus Infection

Overview
Journal Science
Specialty Science
Date 1997 Jun 27
PMID 9197263
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Epstein-Barr virus (EBV) is a human lymphocryptovirus that causes infectious mononucleosis, persists asymptomatically for life in nearly all adults, and is associated with the development of B cell lymphomas and nasopharyngeal carcinomas. A highly similar rhesus lymphocryptovirus naturally endemic in rhesus monkeys was used to orally infect naïve animals from a pathogen-free colony. This animal model reproduced key aspects of human EBV infection, including oral transmission, atypical lymphocytosis, lymphadenopathy, activation of CD23(+) peripheral blood B cells, sustained serologic responses to lytic and latent EBV antigens, latent infection in the peripheral blood, and virus persistence in oropharyngeal secretions. This system may be useful for studying the pathogenesis, prevention, and treatment of EBV infection and associated oncogenesis.

Citing Articles

Sequence Analysis of microRNAs Encoded by Simian Lymphocryptoviruses.

Chen Y, Fachko D, Wu H, Sacha J, Skalsky R Viruses. 2025; 16(12).

PMID: 39772230 PMC: 11680086. DOI: 10.3390/v16121923.


Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.

Edwards K, Schmidt K, Homad L, Kher G, Xu G, Rodrigues K Cell Rep Med. 2024; 5(6):101587.

PMID: 38781964 PMC: 11228584. DOI: 10.1016/j.xcrm.2024.101587.


Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers.

Torne A, Robertson E Cancers (Basel). 2024; 16(5).

PMID: 38473352 PMC: 10931536. DOI: 10.3390/cancers16050991.


Malignancy and viral infections in Sub-Saharan Africa: A review.

Diakite M, Shaw-Saliba K, Lau C Front Virol. 2023; 3.

PMID: 37476029 PMC: 10358275. DOI: 10.3389/fviro.2023.1103737.


The interaction between Epstein-Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities.

Afrasiabi A, Ahlenstiel C, Swaminathan S, Parnell G Clin Transl Immunology. 2023; 12(6):e1454.

PMID: 37337612 PMC: 10276892. DOI: 10.1002/cti2.1454.